Abstract
This chapter presents a comprehensive review of the approaches and methods used to perform clinical ocular scoring of the anterior and posterior segment in laboratory animals in toxicologic and preclinical drug development studies. It represents a distillation and integration of two recent publications from our group with expanded commentary (Eaton et al., J Ocul Pharmacol Ther 33:707–717, 2017; 718–734). The reader is introduced to the indications and features of the most commonly used semi-quantitative scoring systems in laboratory studies, as well as important limitations and considerations for each. The reader is also introduced to the ocular scoring systems employed by the clinical team at Ocular Services On Demand (OSOD), which modify many criteria from previous systems and introduce novel scoring elements to improve the applicability and predictive value of clinical observations made in support of modern preclinical ocular drug and device development programs. Species considerations pertinent to ocular examination and clinical scoring in general toxicology and ocular drug/device development are also discussed.
Endorsed by the American College of Veterinary Ophthalmologists (ACVO).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Eaton JS, Miller PE, Bentley E, Thomasy SM, Murphy CJ. Slit lamp-based ocular scoring systems in toxicology and drug development: a literature survey. J Ocul Pharmacol Ther. 2017;33:707–17.
Eaton JS, Miller PE, Bentley E, Thomasy SM, Murphy CJ. The SPOTS system: an ocular scoring system optimized for use in modern preclinical drug development and toxicology. J Ocul Pharmacol Ther. 2017;33:718–34.
Singer M. Oxford textbook of critical care. New York: Oxford University Press; 2016.
Barbini P, Cevenini G, Furini S, Barbini E. A naive approach for deriving scoring systems to support clinical decision making. J Eval Clin Pract. 2014;20:1–6. https://doi.org/10.1111/jep.12064.
Wilkie DA. The ophthalmic examination as it pertains to general ocular toxicology: basic and advanced techniques and species-associated findings. In: Ocular pharmacology and toxicology. Totowa: Humana Press; 2014. p. 143–203.
Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–16.
BenEzra D, Forrester JV, Nussenblatt RB, Tabbara K, Timonen P. Uveitis scoring system. Berlin: Springer; 1991. p. 1–2.
Deschenes J, Murray PI, Rao NA, Nussenblatt RB. International Uveitis Study Group (IUSG) clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16(1-2):1.
Munger RJ. Veterinary ophthalmology in laboratory animal studies. Vet Ophthalmol. 2002;5:167–75.
Thomasy SM, et al. Species differences in the geometry of the anterior segment differentially affect anterior chamber cell scoring systems in laboratory animals. J Ocul Pharmacol Ther. 2016;32:28–37. https://doi.org/10.1089/jop.2015.0071.
Bito LZ. Species differences in the responses of the eye to irritation and trauma: a hypothesis of divergence in ocular defense mechanisms, and the choice of experimental animals for eye research. Exp Eye Res. 1984;39:807–29.
McDonald TO, Shadduck JA. In: Marzulli FN, Maibach HI, editors. Dermatotoxicology and pharmacology, Advanced in modern toxicology, vol. 4. Washington, DC: Hemisphere; 1977. p. 139–91.
Hackett RB, McDonald TO. Assessing ocular irritation. In: Dermatotoxicology. Washington, DC: Hemisphere; 1996. p. 557–67.
Friedenwald J, Hughes W, Herrmann H. Acid-base tolerance of the cornea. Arch Ophthalmol. 1944;31:279–83.
Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377–90.
Sasaki H, Yamamura K, Nishida K, Nakamura J, Ichikawa M. Delivery of drugs to the eye by topical application. Prog Retin Eye Res. 1996;15:583–620.
Salminen L, Urtti A, Periviita L. Effect of ocular pigmentation on pilocarpine pharmacology in the rabbit eye. I. Drag distribution and metabolism. Int J Pharm. 1984;18:17–24.
Urtti A, Salminen L, Kujari H, Jäntti V. Effect of ocular pigmentation on pilocarpine pharmacology in the rabbit eye. II. Drug response. Int J Pharm. 1984;19:53–61.
Studer ME, Martin CL, Stiles J. Effects of 0.005% latanoprost solution on intraocular pressure in healthy dogs and cats. Am J Vet Res. 2000;61:1220–4.
Gelatt KN, MacKay EO. Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle. Vet Ophthalmol. 2001;4:283–8.
Gelatt KN, MacKay EO. Effect of different dose schedules of bimatoprost on intraocular pressure and pupil size in the glaucomatous Beagle. J Ocul Pharmacol Ther. 2002;18:525–34.
Wilhelmus KR. The Draize eye test. Surv Ophthalmol. 2001;45:493–515. https://doi.org/10.1016/S0039-6257(01)00211-9.
Waring GO, Laibson PR. A systematic method of drawing corneal pathologic conditions. Arch Ophthalmol. 1977;95:1540–2.
Friberg TR, Jenny YY. Chapter 156, Choroidal and retinal folds. In: Albert and Jakobiec’s principles and practice of ophthalmology. 3rd ed. Philadelphia: Elsevier Inc; 2008. p. 2039–48.
Krzystolik MG, Afshari MA, Adamis AP, et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol. 2002;20:338–46.
Nork TM, Dubielzig RR, Christian BJ, et al. Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates. Arch Ophthalmol. 2001;129:1042–52.
Ryan SJ. Subretinal neovascularization: natural history of an experimental model. Arch Ophthalmol. 1982;100:1804–9.
Ohkuma H, Ryan SJ. Experimental subretinal neovascularization in the monkey: permeability of new vessels. Arch Ophthalmol. 1983;101:1102–10.
Jakobiec FA, Stacy RC, Mendoza PR, Chodosh J. Hyperplastic corneal pannus: an immunohistochemical analysis and review. Surv Ophthalmol. 2014;59:448–53.
Williams D. Histological and immunohistochemical evaluation of canine chronic superficial keratitis. Res Vet Sci. 1999;67:191–5.
Gelatt KN, Gilger BC, Kern TJ. Veterinary ophthalmology. Ames: Wiley; 2012.
Dumonde D, et al. Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet. 1982;320:787–92.
Lee EK, Lee S-Y, Yu HG. A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 2015;253:359–68.
Seddon JM, Sharma S, Adelman RA. Evaluation of the clinical age-related maculopathy staging system. Ophthalmology. 2006;113:260–6.
Nussenblatt RB, Palestine AG, Chan C-C, Roberge F. Standardizatlon of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92:467–71.
Kimura SJ, Thygeson P, Hogan MJ. Signs and symptoms of uveitis. II. Classification of the posterior manifestations of uveitis. Am J Ophthalmol. 1959;47:171.
Kempen JH, Ganesh SK, Sangwan VS, Rathinam SR. Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. Am J Ophthalmol. 2008;146:813–8.
Sen HN, et al. A standardized grading system for scleritis. Ophthalmology. 2011;118:768–71. https://doi.org/10.1016/j.ophtha.2010.08.027.
Murphy CJ, Rowland HC. The optics of comparative ophthalmoscopy. Vis Res. 1987;27:599–607.
Agarwal M, Malathi J, Biswas J. Frosted branch angiitis in a patient with typhoid fever. Ocul Immunol Inflamm. 2016:1–3. https://doi.org/10.1080/09273948.2016.1265654.
Wood EH, Wong RW. Bilateral frosted branch angiitis as the presenting sign of antiphospholipid antibody syndrome. J Ophthalmic Inflamm Infect. 2016;6:20.
Short BG. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations. Toxicol Pathol. 2008;36:49–62.
Hosseini A, et al. Efficacy of a phosphorodiamidate morpholino oligomer antisense compound in the inhibition of corneal transplant rejection in a rat cornea transplant model. J Ocul Pharmacol Ther. 2012;28:194–201.
Taradach C, Greaves P, Rubin LF. Spontaneous eye lesions in laboratory animals: incidence in relation to age. CRC Crit Rev Toxicol. 1984;12:121–47.
Taradach C, Regnier B, Perraud J. Eye lesions in Sprague-Dawley rats: type and incidence in relation to age. Lab Anim. 1981;15:285–7.
Wegener A, Kaegler M, Stinn W. Frequency and nature of spontaneous age-related eye lesions observed in a 2-year inhalation toxicity study in rats. Ophthalmic Res. 2002;34(5):281–7.
Eiben R. Frequency of spontaneous opacities in the cornea and lens observed in chronic toxicity studies in Wistar rats: experience with a standardized terminology glossary (Hattersheimer Kreis). Res Commun Pharmacol Toxicol. 2001;6(3/4):238–51.
Bruner RH, Keller WF, Stitzel KA, Sauers LJ, Reer PJ, Long PH, Bruce RD, Alden CL. Spontaneous corneal dystrophy and generalized basement membrane changes in Fischer-344 rats. Toxicol Pathol. 2016;20(3–1):357–66.
Van TW, Balk MW. Spontaneous corneal opacities in laboratory mice. Lab Anim Sci. 1986;36(3):248–55.
Koehn D, Meyer KJ, Syed NA, Anderson MG. Ketamine/xylazine-induced corneal damage in mice. PLoS One. 2015;10:e0132804.
Bawa G, Tkatchenko TV, Avrutsky I, Tkatchenko AV. Variational analysis of the mouse and rat eye optical parameters. Biomed Opt Express. 2013;4:2585–95.
Massof RW, Chang FW. A revision of the rat schematic eye. Vis Res. 1972;12:793–6.
Pe’er J, Muckarem M, Zajicek G. Epithelial cell migration in the normal rat lens. Ann Anat. 1996;178:433–6.
Remtulla S, Hallett P. A schematic eye for the mouse, and comparisons with the rat. Vis Res. 1985;25:21–31.
Mailankot M, et al. Indoleamine 2, 3-dioxygenase overexpression causes kynurenine-modification of proteins, fiber cell apoptosis and cataract formation in the mouse lens. Lab Investig. 2009;89:498.
Sharif NA, et al. Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog. J Ocul Pharmacol Ther. 2006;22:291–309.
Barabino S, Dana MR. Animal models of dry eye: a critical assessment of opportunities and limitations. Investig Ophthalmol Vis Sci. 2004;45:1641–6.
Burgalassi S, Panichi L, Chetoni P, Saettone MF, Boldrini E. Development of a simple dry eye model in the albino rabbit and evaluation of some tear substitutes. Ophthalmic Res. 1999;31:229–35.
Guo Z, et al. Autologous lacrimal-lymphoid mixed-cell reactions induce dacryoadenitis in rabbits. Exp Eye Res. 2000;71:23–31. https://doi.org/10.1006/exer.2000.0855.
Li N, et al. Establishment of the mild, moderate and severe dry eye models using three methods in rabbits. BMC Ophthalmol. 2013;13:50. https://doi.org/10.1186/1471-2415-13-50.
Toshida H, Nguyen DH, Beuerman RW, Murakami A. Neurologic evaluation of acute lacrimomimetic effect of cyclosporine in an experimental rabbit dry eye model. Investig Ophthalmol Vis Sci. 2009;50:2736–41.
Yañez-Soto B, et al. Interfacial phenomena and the ocular surface. Ocul Surf. 2014;12:178–201.
Yánez-Soto B, Leonard BC, Raghunathan VK, Abbott NL, Murphy CJ. Effect of stratification on surface properties of corneal epithelial cells. Invest Ophthalmol Vis Sci. 2015;56:8340–8.
Leonard BC, Yañez-Soto B, Raghunathan VK, Abbott NL, Murphy CJ. Species variation and spatial differences in mucin expression from corneal epithelial cells. Exp Eye Res. 2016;152:43–8.
Kikkawa Y. Normal corneal staining with fluorescein. Exp Eye Res. 1972;14:13–20.
Moore C, Dubielzig R, Glaza S. Anterior corneal dystrophy of American Dutch belted rabbits: biomicroscopic and histopathologic findings. Vet Pathol. 1987;24:28–33.
Port C, Dodd D. Two cases of corneal epithelial dystrophy in rabbits. Lab Anim Sci. 1983;33:587–8.
Holmberg ÅS. Schlemm’s canal and the trabecular meshwork. An electron microscopic study of the normal structure in man and monkey (Cercopithecus ethiops). Doc Ophthalmol. 1965;19:339–73.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Eaton, J.S., Miller, P.E., Bentley, E., Thomasy, S.M., Murphy, C.J. (2018). Standardized Scoring of Ocular Findings in the Context of Drug and Device Development Programs. In: Gilger, B., Cook, C., Brown, M. (eds) Standards for Ocular Toxicology and Inflammation. Springer, Cham. https://doi.org/10.1007/978-3-319-78364-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-78364-2_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-78363-5
Online ISBN: 978-3-319-78364-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)